Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4. - Gong, Ting; Yu, Yan; Yang, Bo; Lin, Min; Huang, Jin-Wen; Cheng, Bo; Ji, Chao (OncoTargets & Therapy, 2018)